Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Isaac Blech Insider Profile
4 Followers
Isaac Blech, Director, Ten Percent Owner at Aevi Genomic Medicine, holds 1.90M shares in Aevi Genomic Medicine (Ticker: GNMX), holds 0.00 shares in InspireMD (Ticker: NSPR), holds 10.00K shares in PDS Biotechnology (Ticker: PDSB).
Isaac Blech Aevi Genomic Medicine (GNMX)Director, Ten Percent Owner
Aevi Genomic Medicine (GNMX)
Director, Ten Percent Owner
Ranked #65,375 out of 78,624 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-34.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Isaac Blech holds in companies
Most Profitable Insider Trade
The most profitable trade made by Isaac Blech
Isaac Blech's Trading History
Aevi Genomic Medicine
Sep 23, 2015
―
Uninformative Sell
944.46K
$440.06K
InspireMD
―
Director
―
$0.00
PDS Biotechnology
Mar 18, 2019
Director
Uninformative Buy
―
$21.20K
Cerecor
―
Director
―
―
X4 Pharmaceuticals
―
Director
―
―
ContraFect
Jul 27, 2017
Director
Informative Buy
19.84K
$8.20M
Diffusion Pharmaceuticals
Aug 30, 2016
Director
Uninformative Buy
―
―
Cerecor Inc
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Isaac Blech's performance on stock
You May Also Like
Isaac Blech insider profile FAQ
What is the percentage of profitable transactions made by Isaac Blech?
The percentage of profitable transactions made by Isaac Blech is 33%.
What is the average return per transaction made by Isaac Blech?
The average return per transaction made by Isaac Blech is -34.10%.
What stocks does Isaac Blech hold?
Isaac Blech holds: GNMX, NSPR, PDSB, CERC, XFOR, CFRX, DFFN, CERCU stocks.
What was Isaac Blech’s latest transaction?
Isaac Blech latest transaction was an Uninformative Sell of $944.46K.
What was Isaac Blech's most profitable transaction?
Isaac Blech’s most profitable transaction was an Informative Buy of CFRX stock on July 27, 2017. The return on the trade was 55.20%.
What is Isaac Blech's role in Aevi Genomic Medicine?
Isaac Blech's role in Aevi Genomic Medicine is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.